Eli Lilly said on Monday it ​would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Several drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results